Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice

Isabel Lastres-Becker1, Susanne Brodesser, Dieter Lütjohann

  • 1Department of Neurology, J.W. Goethe University Medical School, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany.

Human Molecular Genetics
|February 6, 2008
PubMed

Insights

The absence of ataxin-2 protein in mice leads to obesity, insulin resistance, and altered brain signaling. This study reveals new functions for ataxin-2 in metabolic and neurological health.

Area of Science:

  • Neurobiology
  • Molecular Biology
  • Metabolic Research

Background:

  • Ataxin-2 is a protein encoded by the SCA2 gene, linked to Spino-Cerebellar Ataxia type 2.
  • Its precise biological functions beyond associations with polyribosomes and endocytosis are largely unknown.
  • Understanding ataxin-2's role is crucial for neurodegenerative disease research.

Purpose of the Study:

  • To investigate the functional role of ataxin-2 using a knockout mouse model (Sca2(-/-)).
  • To identify physiological and molecular consequences of ataxin-2 deficiency.

Main Methods:

  • Generation and analysis of ataxin-2 deficient (Sca2(-/-)) mice.
  • Phenotypic characterization including fertility, behavior, and metabolic parameters.
  • Molecular analyses of insulin receptor expression, lipid profiles, and signaling pathways in liver and cerebellum.

Main Results:

  • Sca2(-/-) mice displayed reduced fertility and hyperactivity.
  • Deficiency led to abdominal obesity, hepatosteatosis, and insulin resistance by 6 months.
  • Post-transcriptional downregulation of insulin receptor in liver and cerebellum was observed.
  • Altered ganglioside, sulfatide, and cholesterol dynamics were noted in the cerebellum.

Conclusions:

  • Ataxin-2 plays a significant role in regulating metabolic homeostasis and insulin signaling.
  • The protein influences cerebellar lipid metabolism and membrane function.
  • These findings suggest ataxin-2 deficiency impacts cellular signaling pathways relevant to metabolic and neurological disorders.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...